Concentrating management resources in 4 growth areas
First written in FY2023. 3 of 5 entries say "Advanced", first in FY2024-Q3. Latest entry: FY2026.
0 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「In addition, our Group's strengths include expertise in polymer chemistry, molecular design capabilities, and high-speed development systems leveraging formulation technology, through which we have continued to advance ABF™.」
The 4 growth areas were translated into specific products and services, external partnerships, and high-speed development systems in the healthcare, food and wellness, ICT, and green fields. - FY2024AdvancedAnnual report
「Through this acquisition, we aim to accelerate the realization of our roadmap by combining Ajinomoto Group's AminoScience® with Forge's gene therapy CDMO platform, opening up new treatment options for people facing challenges from rare diseases and building a strong business foundation in advanced medicine.」
In healthcare, one of our 4 growth areas, we completed the acquisition of Forge and established a concrete foundation for expanding from gene therapy CDMO services into the cell therapy field. - FY2024-Q3AdvancedAnnual report
「Through this acquisition, we aim to achieve our roadmap ahead of schedule by combining the Ajinomoto Group’s AminoScience® with Forge’s gene therapy CDMO platform, opening new treatment options for people facing the challenges of rare diseases and building a robust business foundation in advanced medicine. Looking toward 2050, we will also enter next-generation business areas based on the technologies and customer relationships we have developed, advance the shift to high-value-added business models, and accelerate growth and improve profitability in healthcare.」
In the healthcare area, one of the 4 growth areas, the acquisition of Forge gave the company a gene therapy CDMO platform, providing a concrete path to accelerating realization of the 2030 roadmap and entering next-generation business areas. - FY2024-Q2RestatedAnnual report
「・AminoScience® ・Technological innovation (food, agriculture, environmental and digital fields)」
The company incorporated AminoScience and technological innovation in the food, agriculture, environmental and digital fields into its materiality initiatives as elements supporting the 4 growth areas. - FY2023First statedAnnual report
「Under the Ajinomoto Group's growth strategy, we are focusing on 4 growth areas—healthcare, food and wellness, ICT, and green—in markets expected to grow over the medium to long term. By leveraging AminoScience®, a distinctive strength of the Ajinomoto Group, we aim to provide social value sustainably and achieve significant growth toward 2030 through reliable growth in existing businesses and growth driven by business model transformation (BMX).」
The company identified healthcare, food and wellness, ICT, and green as 4 growth areas, and established a new growth portfolio aimed at growth toward 2030 through AminoScience® and business model transformation.